146 HLA-B44 motif neoepitope is associated with an anti-tumor immune microenvironment and predicts response to immune checkpoint blockade in non-small cell lung cancer

• Bin Liu,
• Rui Li,
• David Elashoff,
• Edward Garon,
• Aaron Lisberg,
• Maria Velez,
• Tianhao Zhang,
• Tristan Grogan,
• Charlene Fares,
• Gregory Ayzenberg,
• Yazeed Radwan,
• Jackson Lind-lebuffe,
• Paige Brodrick,
• Amy Cummings

Affiliations

Bin Liu

Department of Neurosurgery, the First Medical Center of Chinese PLA General Hospital, Beijing, China

Rui Li

Electrical Engineering and Computer Science, Vanderbilt University, Nashville, Tennessee, USA

David Elashoff

Department of Medicine Statistics Core, Division of General Internal Medicine and Health Services Research, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, USA

Edward Garon

David Geffen School of Medicine, UCLA, University of California Los Angeles, Los Angeles, California, USA

Aaron Lisberg

3UCLA Medical Center, Santa Monica, CA, USA

Maria Velez

UPMC Hillman Cancer Center, Pittsburgh, PA, USA

Tianhao Zhang

Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

Tristan Grogan

1Department of Anesthesiology and Perioperative Medicin, University of California, Los Angeles, Los angeles, USA

Charlene Fares

1David Geffen School of Medicine at University of California, Los Angeles, CA, USA

Gregory Ayzenberg

1David Geffen School of Medicine at University of California, Los Angeles, CA, USA

Yazeed Radwan

1David Geffen School of Medicine at University of California, Los Angeles, CA, USA

Jackson Lind-lebuffe

1David Geffen School of Medicine at University of California, Los Angeles, CA, USA

Paige Brodrick

1David Geffen School of Medicine at University of California, Los Angeles, CA, USA

Amy Cummings

1David Geffen School of Medicine at University of California, Los Angeles, CA, USA